SERONO SAIZEN HUMAN GROWTH HORMONE APPROVED WITH THREE-TIMES WEEKLY DOSING SCHEDULE; SOMATROPIN PRODUCT LABELING CARRIES HYPOTHYROIDISM PRECAUTION
Executive Summary
Serono's Saizen (somatropin) will be marketed with a dosing schedule of three injections per week for children with growth hormone insufficiency following FDA approval Oct. 8.